Format

Send to

Choose Destination
Nat Biotechnol. 2016 Dec 7;34(12):1213-1214. doi: 10.1038/nbt1216-1213.

Alnylam terminates revusiran program, stock plunges.

PMID:
27926717
DOI:
10.1038/nbt1216-1213

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center